- China
- /
- Medical Equipment
- /
- SZSE:301371
Calculating The Intrinsic Value Of Harbin Fuerjia Technology Co., Ltd. (SZSE:301371)
Key Insights
- The projected fair value for Harbin Fuerjia Technology is CN¥25.13 based on 2 Stage Free Cash Flow to Equity
- Harbin Fuerjia Technology's CN¥26.11 share price indicates it is trading at similar levels as its fair value estimate
- Our fair value estimate is 41% lower than Harbin Fuerjia Technology's analyst price target of CN¥42.93
Today we will run through one way of estimating the intrinsic value of Harbin Fuerjia Technology Co., Ltd. (SZSE:301371) by taking the expected future cash flows and discounting them to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
See our latest analysis for Harbin Fuerjia Technology
The Model
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) forecast
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
Levered FCF (CN¥, Millions) | CN¥509.0m | CN¥505.3m | CN¥507.1m | CN¥512.7m | CN¥521.0m | CN¥531.4m | CN¥543.4m | CN¥556.6m | CN¥570.8m | CN¥585.9m |
Growth Rate Estimate Source | Est @ -2.25% | Est @ -0.72% | Est @ 0.35% | Est @ 1.10% | Est @ 1.63% | Est @ 1.99% | Est @ 2.25% | Est @ 2.43% | Est @ 2.56% | Est @ 2.64% |
Present Value (CN¥, Millions) Discounted @ 7.4% | CN¥474 | CN¥438 | CN¥409 | CN¥385 | CN¥364 | CN¥346 | CN¥329 | CN¥314 | CN¥299 | CN¥286 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CN¥3.6b
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We discount the terminal cash flows to today's value at a cost of equity of 7.4%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = CN¥586m× (1 + 2.9%) ÷ (7.4%– 2.9%) = CN¥13b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CN¥13b÷ ( 1 + 7.4%)10= CN¥6.4b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is CN¥10b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of CN¥26.1, the company appears around fair value at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
Important Assumptions
We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Harbin Fuerjia Technology as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.4%, which is based on a levered beta of 0.921. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Harbin Fuerjia Technology
- Currently debt free.
- Dividends are covered by earnings and cash flows.
- Dividend is in the top 25% of dividend payers in the market.
- Earnings declined over the past year.
- Shareholders have been diluted in the past year.
- Annual earnings are forecast to grow for the next 3 years.
- Good value based on P/E ratio compared to estimated Fair P/E ratio.
- Annual earnings are forecast to grow slower than the Chinese market.
Next Steps:
Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Harbin Fuerjia Technology, we've compiled three fundamental elements you should consider:
- Risks: Take risks, for example - Harbin Fuerjia Technology has 2 warning signs we think you should be aware of.
- Future Earnings: How does 301371's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SZSE every day. If you want to find the calculation for other stocks just search here.
Valuation is complex, but we're here to simplify it.
Discover if Harbin Fuerjia Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:301371
Harbin Fuerjia Technology
Engages in the research, development, production, and sale of skin care products in China.
Flawless balance sheet average dividend payer.